Contracts Keep Drug Research Out of Reach
655242
Academic institutions and researchers are widely viewed as impartial actors in drug trials. But that independence often comes with strings attached.
329729
Scientists are chafing at the U.S. government's unfulfilled pledge to boost funding for basic scientific research, the source of innovations ranging from the World Wide Web to high-tech cancer treatments.
145071
A drug used to treat breast cancer would not be good for preventing the tumours occurring in the first place, say researchers.
138928
Misaligned incentives are leading two potentially life-saving drugs for treating lymphoma to go underused.
378783
The Food and Drug Administration lacks clear regulatory authority and is chronically underfunded, shortcomings hindering its ability to evaluate the safety of drugs used by millions of Americans, according to outside scientists the agency asked to critique its performance.
705622
Drug companies are fighting most of the state initiatives, which they say will deny patients access to valuable treatments.
303738
Drug and medical device makers will not be forced to disclose the results of clinical trials on some products that never reached the marketplace.
330991
Doctors are missing key information they need to make decisions for cancer patients because some drug companies are not publishing clinical trials.
56039
The Food and Drug Administrationâs proposed rules would allow drug and device makers to provide doctors with medical journal articles about product uses that have not been approved by the F.D.A.
560328
Scientists and consumer groups say current patents are hindering research in a field that holds great medical promise.
560418
The initiative is part of an effort to ferret out unpublished research consucted by pharmaceutical companies that finds medications to be ineffective or dangerous.
158632
When Raymond Gilmartin became chairman of the drug maker Merck, it was close to introducing several new medicines. Now, the company is in crisis.
286537
A battle between insurers and drug companies could determine how many medicines will be available to beneficiaries.
150133
Academic institutions and researchers are often seen as impartial actors in drug trials, but sometimes independence comes with strings attached.
640534
Its failure to acquiesce to the FDA's request means the competition is going forward as this drugmaker's product stays stagnant.
174927
Pressure is building against the widely reported gifts and other potential conflicts between drug companies and doctors.
55328
Drug companies which fail to disclose the results of clinical trials are harming the treatment of cancer patients, doctors say.